Product Images Duloxetine Hydrochloride 20 Mg

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Duloxetine Hydrochloride 20 Mg NDC 46708-128 by Alembic Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

20mg HDPE Bottle Pack - duloxetine 20

20mg HDPE Bottle Pack - duloxetine 20

This appears to be a description of a medication called Duloxetine, which comes in capsules containing 2.4mg of the active ingredient (Duvetine). The medication is meant to be kept in a closed container out of reach of children, stored at 5°C (around 41°F), and should only be taken as directed by a healthcare provider. The packaging includes a medication guide for patients and is available in a 30-capsule quantity. Additional information, such as expiration date, is unavailable from the given text.*

30mg HDPE Bottle Pack - duloxetine 30

30mg HDPE Bottle Pack - duloxetine 30

60mg HDPE Bottle Pack - duloxetine 60

60mg HDPE Bottle Pack - duloxetine 60

Each capsule contains 67.3 mg of duloxetine hydrochloride USP equivalent to 60 mg duloxetine. Please refer to accompanying literature for dosage instructions. The capsules should be kept in a tightly closed container, stored at a temperature of 25°C (77°F) with excursion permitted to 15° to 30°C (59°F to 86°F), and kept out of the reach of children. Do not use if inner seal is missing or broken. This medication should only be dispensed by a USP Controlled Room pharmacy. Dispense the accompanying Medication Guide to each patient. Manufactured by Alembic Pharmaceuticals Limited's Formulation Division in India. This product is only available by prescription and comes in a package containing 30 capsules.*

duloxetine-figure-1 - duloxetine figure 1

duloxetine-figure-1 - duloxetine figure 1

duloxetine-figure-2 - duloxetine figure 2

duloxetine-figure-2 - duloxetine figure 2

This document shows the percentage of patients who improved in pain from baseline when taking either Duloxetine 60mg BID or Duloxetine 60mg QD compared to placebo. The chart includes data points at 210, 220, 230, 240, 250, 260, 270 with corresponding percent improvements.*

figure-3 - duloxetine figure 3

figure-3 - duloxetine figure 3

figure-4 - duloxetine figure 4

figure-4 - duloxetine figure 4

This document appears to be a graph showing the percentage of patients improved after taking Duloxetine 60 mg once daily. The x-axis ranges from 210 to 280 and the y-axis ranges from 0 to 100. The graph shows that 100% of patients experienced improvement. The text "Percent Improvement in Pain from Baseline (BOCF)" indicates that the patients were likely experiencing pain prior to treatment with Duloxetine.*

figure-5 - duloxetine figure 5

figure-5 - duloxetine figure 5

This is a chart that shows the percentage of patients who experienced improvement in pain from baseline after taking a placebo or Duloxetine in doses of 60/120 mg once daily. The chart includes numbers ranging from 0 to 100, representing different levels of improvement.*

duloxetine-structure - duloxetine structure

duloxetine-structure - duloxetine structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.